In:
Science, American Association for the Advancement of Science (AAAS), Vol. 226, No. 4676 ( 1984-11-16), p. 864-866
Abstract:
Clonidine, an α-2-adrenergic agonist, significantly reduces opiate withdrawal. Fifteen heavy smokers abstained from cigarettes on three separate occasions and received instead clonidine, placebo, or the benzodiazepine alprazolam. Clonidine and alprazolam diminished withdrawal symptoms. The two drugs suppressed anxiety, tension, irritability, and restlessness equally but clonidine had a greater effect than alprazolam on cigarette craving. These observations suggest that noradrenergic activity is a common feature in the pathophysiology of withdrawal and that a special relationship exists between central noradrenergic activity and craving.
Type of Medium:
Online Resource
ISSN:
0036-8075
,
1095-9203
DOI:
10.1126/science.6387913
Language:
English
Publisher:
American Association for the Advancement of Science (AAAS)
Publication Date:
1984
detail.hit.zdb_id:
128410-1
detail.hit.zdb_id:
2066996-3
SSG:
11